ISSN: 2708-1893

［1］FERRUCCI L, REIRE M G, FABBRI E, et al. Measuring biological aging in humans: a quest［J］. Aging Cell, 2019, 19(2): 13080-13401. DOI:10.1111/acel.13080. ［2］HOU Yujun, DAN Xiuli, BABBAR M, et al. Ageing as a risk factor for neurodegenerative disease［J］. Nature Reviews Neurology, 2019, 15(10): 565-581. DOI:10.1038/s41582-019-0244-7. ［3］PIVTORAIKO V N, ROTH K A. Neurodegeneration: the molecular pathology of dementia and movement disorders［M］. 2nd ed. John Wiley and Sons Ltd, 2011. ［4］NAZAM F, SHAIKH S, NAZAM N, et al. Molecular and cellular biochemistry mechanistic insights into the pathogenesis of neurodegenerative diseases: towards the development of effective therapy［J］. Molecular and Cellular Biochemistry, 2021, 476(7): 2739-2752. DOI:10.1007/s11010-021-04120-6. ［5］AGOSTA F, GALANTUCCI S, FILIPPI M. Advanced magnetic resonance imaging of neurodegenerative diseases［J］. Neurological Sciences, 2017, 38(1): 41-51. DOI:10.1007/s10072-016-2764-x. ［6］KAUR D, SHARMA V, DESHMUKH R. Activation of microglia and astrocytes: a roadway to neuroinflammation and Alzheimer’s disease［J］. Inflammopharmacology, 2019, 27(4): 663-677. DOI:10.1007/s10787-019-00580-x. ［7］LI Ping, FENG Dou, YANG Dacheng, et al. Protective effects of anthocyanins on neurodegenerative diseases［J］. Trends in Food Science & Technology, 2021, 17(11):1-13. DOI:10.1016/j.tifs.2021.05.005. ［8］Alzhimer’s Disease International. World Alzheimer Report 2010: the Global Economic Impact of Dementia\[R\]. Anders Wimo, Martin: Alzhimer’s Disease International, 2010. ［9］杨青, 贾杰. 阿尔兹海默病相关指南及专家共识解读—全周期康复新视角［J］. 中国医刊, 2021, 56(1): 22-27. DOI:10.3969/j.issn.1008-1070.2021.01.007. ［10］JIA Jianping, WEI Cuibai, CHEN Shuoqi, et al. The cost of Alzheimer’s disease in China and re-estimation of costs worldwide［J］. Alzheimer’s and Dementia, 2018, 14(4): 483-491. DOI:10.1016/j.jalz.2017.12.006. ［11］POJER E, MATTIVI F, JOHNSON D, et al. The case for anthocyanin consumption to promote human health: a review［J］. Comprehensive Reviews in Food Science & Food Safety, 2013, 12(5): 483-508. DOI:10.1111/1541-4337.12024. ［12］CSEDAS G, LES F, GMEZ-SERRANILLOS M P, et al. Anthocyanin profile, antioxidant activity and enzyme inhibiting properties of blueberry and cranberry juices: a comparative study［J］. Food & Function, 2017, 8(11): 4187-4193. DOI:10.1039/c7fo01205e. ［13］MATTIOLI R, FRANCIOSO A, MOSCA L, et al. Anthocyanins: a comprehensive review of their chemical properties and health effects on cardiovascular and neurodegenerative diseases［J］. Molecules, 2020, 25(17): 3809-3851. DOI:10.3390/molecules25173809. ［14］ESRA S, ROGERS G T, BLUMBERG J B, et al. Long-term dietary flavonoid intake and risk of Alzheimer’s disease and related dementias in the Framingham Offspring Cohort［J］. The American Journal of Clinical Nutrition, 2020, 112(2): 343-353. DOI:10.1093/ajcn/nqaa079. ［15］SHIH P H, CHAN Y C, LIAO J W, et al. Antioxidant and cognitive promotion effects of anthocyanin-rich mulberry (Morus atropurpurea L.) on senescence-accelerated mice and prevention of Alzheimer’s disease［J］. Journal of Nutritional Biochemistry, 2010, 21(7): 598-605. DOI:10.1016/j.jnutbio.2009.03.008. ［16］GUTIERRES J M, CARVALHO F B, SCHETINGER M, et al. Neuroprotective effect of anthocyanins on acetylcholinesterase activity and attenuation of scopolamine-induced amnesia in rats［J］. International Journal of Developmental Neuroscience, 2014, 33(1): 88-97. DOI:10.1016/j.ijdevneu.2013.12.006. ［17］REHMAN S U, SHAH S A, ALI T, et al. Anthocyanins reversed D-galactose-induced oxidative stress and neuroinflammation mediated cognitive impairment in adult rats［J］. Molecular Neurobiology, 2017, 54(1): 255-271. DOI:10.1007/s12035-015-9604-5. ［18］SONG Nan, YANG Hongpeng, PANG Wei, et al. Mulberry extracts alleviate Aβ25-35-induced injury and change the gene expression Pprofile in PC12 cells［J］. Evidence-based Complementary & Alternative Medicine (eCAM), 2014, 2014(1741-427X): 1-9. DOI:10.1155/2014/150617. ［19］CLAUDINE, MANACH, GARY, et al. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies1,2,3［J］. American Journal of Clinical Nutrition, 2005, 81(1): 230-242. DOI:10.1021/jo070579k. ［20］MCGHIE T K, WALTON M C. The bioavailability and absorption of anthocyanins: towards a better understanding［J］. Molecular Nutrition & Food Research, 2007, 51(6): 702-713. DOI:10.1002/mnfr.200700092. ［21］TALAVRA S, FELGINES C, TEXIER O, et al. Anthocyanins are efficiently absorbed from the small intestine in rats［J］. Journal of Nutrition, 2004, 134(9): 2275-2279. DOI:10.1089/jmf.2004.7.381. ［22］KAY C D. Aspects of anthocyanin absorption, metabolism and pharmacokinetics in humans［J］. Nutrition Research Reviews, 2006, 19(01): 137-146. DOI:10.1079/NRR2005116. ［23］MIYAZAWA T, NAKAGAWA K, KUDO M, et al. Direct intestinal absorption of red fruit anthocyanins, cyanidin-3-glucoside and cyanidin-3,5-diglucoside, into rats and humans［J］. Journal of Agricultural & Food Chemistry, 1999, 47(3): 1083-1091. DOI:10.1021/jf9809582. ［24］TENG Hui, CHEN Lei. Polyphenols and bioavailability: an update［J］. Critical Reviews in Food Science and Nutrition, 2019, 59(13): 2040-2051. DOI:10.1080/10408398.2018.1437023. ［25］CRISTINA A L, BARBARA S H, GALLI R L, et al. Anthocyanins in aged blueberry-fed rats are found centrally and may enhance memory［J］. Nutritional Neuroscience, 2005, 8(2): 111-120. DOI:10.1080/10284150500078117. ［26］SVERINE T, CATHERINE F, ODILE T, et al. Anthocyanin metabolism in rats and their distribution to digestive area, kidney, and brain［J］. Journal of Agricultural and Food Chemistry, 2005, 53(10): 3902-3908. DOI:10.1021/jf050145v. ［27］PASSAMONTI S, VRHOVSEK U, VANZO A, et al. Fast access of some grape pigments to the brain［J］. Journal of Agricultural & Food Chemistry, 2005, 53(18): 7029-7034. DOI:10.1021/jf050565k. ［28］FARIA A, PESTANA D, TEIXEIRA D, et al. Flavonoid transport across RBE4 cells: a blood-brain barrier model［J］. Cellular & Molecular Biology Letters, 2010, 15(2): 234-241. DOI:10.2478/s11658-010-0006-4. ［29］YAMAKAWA M Y, UCHINO K, WATANABE Y, et al. Anthocyanin suppresses the toxicity of Aβ deposits through diversion of molecular forms in in vitro and in vivo models of Alzheimer’s disease［J］. Nutritional Neuroscience, 2015, 19(1): 32-42. DOI:10.1179/1476830515Y.0000000042. ［30］LIU Fufeng, ZHAO Fan, WANG Wenjuan, et al. Cyanidin-3-O-glucoside inhibits Aβ40 fibrillogenesis, disintegrates preformed fibrils, and reduces amyloid cytotoxicity［J］. Food & Function, 2020, 11(3): 1-47. DOI:10.1039/C9FO00316A. ［31］RIVIRE C, RICHARD T, VITRAC X, et al. New polyphenols active on beta-amyloid aggregation［J］. Bioorganic & Medicinal Chemistry Letters, 2008, 18(2): 828-831. DOI:10.1016/j.bmcl.2007.11.028. ［32］温海超. 矢车菊素-3-O-半乳糖苷改善阿尔兹海默病模型动物认知能力机制研究\[D\]. 北京: 中国农业大学, 2021:62-67. ［33］TANIGUCHI S, SUZUKI N, MASUDA M, et al. Inhibition of heparin-induced tau filament formation by phenothiazines, polyphenols, and porphyrins［J］. Journal of Biological Chemistry, 2005, 280(9): 7614-7623. DOI:10.1074/jbc.M408714200. ［34］HAN X, SHEN T, LOU H. Dietary polyphenols and their biological significance［J］. International Journal of Molecular Sciences, 2007, 8(9): 950-988. DOI:10.3390/i8090950. ［35］QUINT H R, GALIGNIANA M D. The neuroregenerative mechanism mediated by the hsp90-binding immunophilin FKBP52 resembles the early steps of neuronal differentiation［J］. 2015, 166(2): 637-649. DOI:10.1111/j.1476-5381.2011.01783.x. ［36］QUINT H R, MASCHI D, GOMEZ-SANCHEZ C, et al. Subcellular rearrangement of hsp90‐binding immunophilins accompanies neuronal differentiation and neurite outgrowth［J］. Journal of Neurochemistry, 2010, 115(3): 716-734. DOI:10.1111/j.1471-4159.2010.06970.x. ［37］HUNG T C, CHANG T T, FAN M J, et al. In silico insight into potent of anthocyanin regulation of FKBP52 to prevent Alzheimer’s Disease［J］. Evidence Based Complementary & Alternative Medicine Ecam, 2014, 2014:1-20. DOI:10.1155/2014/450592. ［38］AVILA J, HERNNDEZ F. GSK-3 inhibitors for Alzheimer’s disease［J］. Expert Review of Neurotherapeutics, 2007, 7(11): 1527-1533. DOI:10.1586/14737175.7.11.1527. ［39］GIESE K P. GSK-3: a key player in neurodegeneration and memory［J］. Iubmb Life, 2010, 61(5): 516-521. DOI:10.1002/iub.187. ［40］PEI Jinjing J, EVA B, HEIKO B, et al. Distribution of active glycogen synthase kinase 3beta (GSK-3beta) in brains staged for Alzheimer’s disease neurofibrillary changes［J］. Journal of Neuropathology & Experimental Neurology, 1999, 58(9): 1010-1019. DOI:10.1097/00005072-199909000-00011. ［41］ALI T, KIM M J, REHMAN S U, et al. Anthocyanin-loaded PEG-gold nanoparticles enhanced the neuroprotection of anthocyanins in an Aβ1-42 mouse model of Alzheimer’s Disease［J］. Molecular Neurobiology, 2017, 54(8): 6490-6506. DOI:10.1007/s12035-016-0136-4. ［42］CALISSANO P, MATRONE C, AMADORO G. Apoptosis and in vitro Alzheimer’s disease neuronal models［J］. Communicative and Integrative Biology, 2009, 2(2): 163-169. DOI:10.4161/cib.7704. ［43］LU Jun, WU Dongmei, ZHENG Yuanlin, et al. Purple sweet potato color alleviates D-galactose-induced brain aging in old mice by promoting survival of neurons via PI3K pathway and inhibiting cytochrome C-mediated apoptosis［J］. Brain Pathology, 2010, 20(3): 598-612. DOI:10.1111/j.1750-3639.2009.00339.x. ［44］ULLAH I, PARK H Y, KIM M O. Anthocyanins protect against kainic acid-induced excitotoxicity and apoptosis via ROS-activated AMPK pathway in hippocampal neurons［J］. Cns Neuroscience & Therapeutics, 2014, 20(4): 327-338. DOI:10.1111/cns.12218. ［45］WEN Haichao, CUI Hui, TIAN Hehe, et al. Isolation of neuroprotective anthocyanins from black chokeberry (Aronia melanocarpa) against amyloid-β-induced cognitive impairment［J］. Foods, 2020, 10(1): 63-77. DOI:10.3390/foods10010063. ［46］DASKALOVA E, DELCHEV S, TOPOLOV M, et al. Aronia melanocarpa (Michx.) Elliot fruit juice reveals neuroprotective effect and improves cognitive and locomotor functions of aged rats［J］. Food and Chemical Toxicology, 2019, 132(2019): 110674-110702. DOI:10.1016/j.fct.2019.110674. ［47］SUNG M K, CHUNG M J, HA T J, et al. Neuroprotective effects of black soybean anthocyanins via inactivation of ASK1-JNK/p38 pathways and mobilization of cellular sialic acids［J］. Life Sciences, 2012, 90(21-22): 874-882. DOI:10.1016/j.lfs.2012.04.025. ［48］BADSHAH H, KIM T H, KIM M O. Protective effects of anthocyanins against amyloid beta-induced neurotoxicity in vivo and in vitro［J］. Neurochemistry International, 2014, 80(2015): 51-59. DOI:10.1016/j.neuint.2014.10.009. ［49］YOU Mingyao, CAI Yinhao, FAN Zhudi, et al. Protective effect of Cy-3G on PC12 cells against beta-amyloid-induced apoptosis and the possible mechanism［J］. International Journal of Clinical and Experimental Medicine, 2017, 10(3): 4565-4573. ［50］BELKACEMI A, RAMASSAMY C, GHRIBI O. Anthocyanins protect SK-N-SH Cells against acrolein-induced toxicity by preserving the cellular redox state［J］. Journal of Alzheimer’s Disease, 2016, 50(4): 981-998. DOI:10.3233/JAD-150770. ［51］MADORE C, YIN Z, LEIBOWITZ J, et al. Microglia, lifestyle stress, and neurodegeneration［J］. Immunity, 2020, 52(2): 222-240. DOI:10.1016/j.immuni.2019.12.003. ［52］BISHT K, SHARMA K, TREMBLAY M . Chronic stress as a risk factor for Alzheimer’s disease: roles of microglia-mediated synaptic remodeling, inflammation, and oxidative stress［J］. Neurobiology of Stress, 2018, 9(2018): 9-21. DOI:10.1016/j.ynstr.2018.05.003. ［53］KATSUMOTO A, TAKEUCHI H, TAKAHASHI K, et al. Microglia in Alzheimer’s disease: risk factors and inflammation［J］. Frontiers in neurology electronic resource, 2018, 9(2018): 978-985. DOI:10.3389/fneur.2018.00978. ［54］PHAN T, MALKANI R. Sleep and circadian rhythm disruption and stress intersect in Alzheimer’s disease［J］. Neurobiology of Stress, 2018, 10(2019): 100133-100146. DOI:10.1016/j.ynstr.2018.10.001. ［55］BAALMAN K, MARIN M A, HO S Y, et al. Axon initial segment-associated microglia［J］. The Journal of Neuroscience: the Official Journal of the Society for Neuroscience, 2015, 35(5): 2283-2292. DOI:10.1523/JNEUROSCI.3751-14.2015. ［56］SAVIC D, STOJILJKOVIC M, LAVRNJA I, et al. Ribavirin shows immunomodulatory effects on activated microglia［J］. Immunopharmacology and Immunotoxicology, 2014, 36(6): 433-441. DOI:10.3109/08923973.2014.971962. ［57］CAREY A N, FISHER D R, RIMANDO A M, et al. Stilbenes and anthocyanins reduce stress signaling in BV-2 mouse microglia［J］. Journal of Agricultural & Food Chemistry, 2013, 61(25): 5979-5986. DOI:10.1021/jf400342g. ［58］LI Jing, ZHAO Runtian, JIANG Yuhan, et al. Bilberry anthocyanins improve neuroinflammation and cognitive dysfunction in APP/PSEN1 mice via the CD33/TREM2/TYROBP signaling pathway in microglia［J］. Food & Function, 2020, 11(2): 1572-1584. DOI:10.1039/C9FO02103E. ［59］MU Teng, GUAN Yang, CHEN Tianqiao, et al. Black raspberry anthocyanins protect BV2 microglia from LPS-induced inflammation through down-regulating NOX2/TXNIP/NLRP3 signaling［J］. Journal of Berry Research, 2021, 11(10): 1-15. DOI:10.3233/JBR-200692. ［60］李建光, 阳莹, 刘倩芸, 等. 黑果小檗总花色苷对Aβ25-35诱导的AD小鼠及小胶质细胞神经炎性反应模型的影响［J］. 中华中医药杂志, 2017, 32(2): 424-427. DOI:CNKI:SUN:BXYY.0.2017-02-111. ［61］雷洪涛, 王筠, 马淑骅, 等. IL-1β、TNF-α 与阿尔兹海默病的研究进展［J］. 中国老年学, 2014, 000(024): 7115-7117. DOI:10.3969/j.issn.1005-9202.2014.24.137. ［62］TORO V C, TEHRANIAN R, ZETTERSTRM M, et al. Increased gene expression of interleukin-1α and interleukin-6 in rat primary glial cells induced by β-amyloid fragment［J］. Journal of Molecular Neuroscience, 2001, 17(3): 341-350. DOI:10.1385/JMN:17:3:341. ［63］HAMBY M E, SOFRONIEW M V. Reactive astrocytes as therapeutic targets for CNS disorders［J］. Journal of the American Society for Experimental NeuroTherapeutics, 2010, 7(4): 494-506. DOI:10.1016/j.nurt.2010.07.003. ［64］KHAN M S, ALI T, KIM M W, et al. Anthocyanins protect against LPS-induced oxidative stress-mediated neuroinflammation and neurodegeneration in the adult mouse cortex［J］. Neurochemistry International, 2016, 100(2016): 1-10. DOI:10.1016/j.neuint.2016.08.005. ［65］ZHAN Xinhua, BORYANA S, SHARP F R. Lipopolysaccharide associates with amyloid plaques, neurons and oligodendrocytes in Alzheimer’s disease brain: a review［J］. Frontiers in Aging Neuroscience, 2018, 42(10): 1-14. DOI:10.3389/fnagi.2018.00042. ［66］RIEDER R, WISNIEWSKI P J, ALDERMAN B L, et al. Microbes and mental health: a review［J］. Brain Behavior & Immunity, 2017, 6(2017): 9-17. DOI:10.1016/j.bbi.2017.01.016. ［67］CLARKE G, GRENHAM S, SCULLY P, et al. The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner［J］. Molecular psychiatry, 2013, 18(6): 666-673. DOI:10.1038/mp.2012.77. ［68］REA K, DINAN T G, CRYAN J F. The microbiome: a key regulator of stress and neuroinflammation［J］. Neurobiology of Stress, 2016, 4(C): 23-33. DOI:10.1016/j.ynstr.2016.03.001. ［69］LYTE M, CRYAN J F. Microbial endocrinology: the microbiota-gut-brain axis in health and disease［M］. New York: Springer New York Heidelberg Dordrecht, 2014:1-440. DOI:10.1007/978-1-4939-0897-4_1. ［70］LYTE M, MILLER V. Microbial endocrinology in the microbiome-gut-brain axis: how bacterial production and utilization of neurochemicals influence behavior［J］. Plos Pathogens, 2013, 9(11): 1003726-1003729. DOI:10.1371/journal.ppat.1003726. ［71］CARDONA F, ANDRS-LACUEVA C, TULIPANI S, et al. Benefits of polyphenols on gut microbiota and implications in human health［J］. Journal of Nutritional Biochemistry, 2013, 24(8): 1415-1422. DOI:10.1016/j.jnutbio.2013.05.001. ［72］KEPPLER K, Humpf H U. Metabolism of anthocyanins and their phenolic degradation products by the intestinal microflora［J］. Bioorganic and Medicinal Chemistry, 2005, 17(13): 5195-5205. DOI:10.1016/j.bmc.2005.05.003. ［73］FARIA A, MEIRELES M, FERNANDES I, et al. Flavonoid metabolites transport across a human BBB model［J］. Food Chemistry, 2014, 149(2014): 190-196. DOI:10.1016/j.foodchem.2013.10.095. ［74］TALAVERA S, FELGINES C, TEXIER O, et al. Anthocyanin metabolism in rats and their distribution to digestive area, kidney, and brain［J］. Journal of Agricultural and Food Chemistry, 2005, 53(10): 3902-3908. DOI:10.1021/jf050145v. ［75］WANG Dongjie, LAP H, JEREMIAH F, et al. Role of intestinal microbiota in the generation of polyphenol‐derived phenolic acid mediated attenuation of Alzheimer’s disease β‐amyloid oligomerization［J］. Molecular Nutrition and Food Research, 2015, 59(6): 1025-1040. DOI:10.1002/mnfr.201400544. ［76］JAEGER B N, PARYLAK S L, GAGE F H, et al. Mechanisms of dietary flflavonoid action in neuronal function and neuroinflflammation［J］. Molecular Aspects of Medicine, 2018, 61(2018): 50-62. DOI:10.1016/j.mam.2017.11.003. ［77］CRYAN J F, O’RIORDAN K J, COWAN C, et al. The microbiota-gut-brain Axis［J］. Physiological Reviews, 2019, 99(4): 1877-2013. DOI:10.1152/physrev.00018.2018. ［78］MANCUSO C, SANTANGELO R. Alzheimer’s disease and gut microbiota modifications: the long way between preclinical studies and clinical evidence［J］. Pharmacological Research, 2017, 129(2018): 329-336. DOI:10.1016/j.phrs.2017.12.009. ［79］NAVIGLIO D. Short-chain fatty acids and lipopolysaccharide as mediators between gut dysbiosis and amyloid pathology in Alzheimer’s disease［J］. Journal of Alzheimer’s disease: JAD, 2020, 78(2): 1-15. DOI:10.3233/JAD-200306. ［80］OSORIO C, KANUKUNTL T, DIAZ E, et al. The post-amyloid ara in Alzheimer’s disease: trust your gut feeling［J］. Frontiers in Aging Neuroscience, 2019, 11(2019): 143-170. DOI:10.3389/fnagi.2019.00143.